This compound is a complex beta-lactam derivative, specifically a cephalosporin analog, used primarily as an antibiotic agent rather than a standalone beta-lactamase inhibitor. It features a cephem nucleus with a 7-methoxy group and a 3-[(1-methyl-1H-tetrazol-5-yl)thio]methyl substituent, which enhance its stability against beta-lactamase enzymes and improve penetration into bacterial cells. The unique side chain at the 7-position, involving a 1,3-dithietane ring and an amino-carboxy-ethylidene moiety, contributes to its broad-spectrum activity against Gram-negative bacteria, including multidrug-resistant strains.

It is employed in the treatment of serious infections such as urinary tract infections, respiratory tract infections, and sepsis, particularly in hospital settings. Due to its structural features, it resists degradation by beta-lactamases, allowing effective use against resistant pathogens. In pharmaceutical research, this compound serves as a key intermediate or scaffold for synthesizing novel beta-lactam antibiotics with optimized pharmacokinetics, reduced side effects, and enhanced specificity.